Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Am Acad Dermatol ; 77(1): 33-41.e1, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28341348

RESUMEN

BACKGROUND: There is a rationale for adding systemic photoprotective agents to the current photoprotection regimen. OBJECTIVE: This study was designed to objectively evaluate the molecular and photobiologic effects of oral administration of Polypodium leucotomos extract (PLE). METHODS: In all, 22 subjects with Fitzpatrick skin phototype I to III were enrolled. On day 1, subjects were irradiated with visible light, ultraviolet (UV) A1, and UVB (using 308-nm excimer laser). Evaluation was done immediately and 24 hours after irradiation. On days 3 and 4, irradiation and evaluation process was repeated after ingestion of PLE. RESULTS: Clinical assessments and colorimetry data showed a decrease in UVB-induced changes in 17 of 22 subjects post-PLE administration; histology findings demonstrated such a decrease in all 22 subjects. LIMITATIONS: Only 2 doses of PLE were given. Furthermore, subjects with skin phototypes I to III only were studied. CONCLUSION: The results suggest that PLE can potentially be used as an adjunctive agent to lessen the negative photobiologic effects of UVB.


Asunto(s)
Extractos Vegetales/farmacología , Polypodium , Piel/efectos de los fármacos , Piel/efectos de la radiación , Rayos Ultravioleta , Administración Oral , Femenino , Humanos , Masculino , Extractos Vegetales/administración & dosificación
2.
J Am Acad Dermatol ; 76(5): 879-888, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28216034

RESUMEN

BACKGROUND: Treatment of vitiligo with narrowband ultraviolet B light (NBUVB) is an important component of the current standard of care. However, there are no consistent guidelines regarding the dosing and administration of NBUVB in vitiligo, reflected by varied treatment practices around the world. OBJECTIVE: To create phototherapy recommendations to facilitate clinical management and identify areas requiring future research. METHODS: The Vitiligo Working Group (VWG) Phototherapy Committee addressed 19 questions regarding the administration of phototherapy over 3 conference calls. Members of the Photomedicine Society and a group of phototherapy experts were surveyed regarding their phototherapy practices. RESULTS: Based on comparison and analysis of survey results, expert opinion, and discussion held during conference calls, expert recommendations for the administration of NBUVB phototherapy in vitiligo were created. LIMITATIONS: There were several areas that required further research before final recommendations could be made. In addition, no standardized methodology was used during literature review and to assess the strength of evidence during the development of these recommendations. CONCLUSION: This set of expert recommendations by the VWG is based on the prescribing practices of phototherapy experts from around the world to create a unified, broadly applicable set of recommendations on the use of NBUVB in vitiligo.


Asunto(s)
Terapia Ultravioleta/métodos , Terapia Ultravioleta/normas , Vitíligo/radioterapia , Quimioterapia Adyuvante , Consenso , Humanos , Guías de Práctica Clínica como Asunto , Dosificación Radioterapéutica/normas , Terapia Ultravioleta/efectos adversos
3.
Photodermatol Photoimmunol Photomed ; 32(2): 66-80, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26662644

RESUMEN

While narrowband ultraviolet light B (NB-UVB) has become integral to the treatment of diffuse vitiligo, evidence-based guidelines have been lacking with regard to dosing and administration. This is largely the result of heterogeneous study designs, ambiguous methodologies, disparate dosing strategies, and the use of varied, and somewhat arbitrary, outcome measures. In the absence of prospective trials to address each of these concerns, the available literature regarding the application of NB-UVB for vitiligo was reviewed and the authors now pose a set of questions to the phototherapy community in an attempt to highlight gaps within our understanding. We aim to stimulate discussion, elicit expert opinion, and identify areas for future research to move toward a unified and safe treatment guideline for patients afflicted by this disease.


Asunto(s)
Rayos Ultravioleta , Terapia Ultravioleta/métodos , Vitíligo/terapia , Humanos
4.
J Cutan Aesthet Surg ; 8(2): 79-87, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26157306

RESUMEN

Vitiligo is an acquired skin disorder characterized by the destruction of melanocytes resulting in achromic macules and patches involving the affected skin. Multiple methods of treatments have emerged to manage vitiligo, including medical and surgical techniques. Among the surgical techniques described in the management of vitiligo are minipunch grafting, split-thickness skin grafting, hair follicle transplantation, suction blister grafting, and cultured and non-cultured autologous melanocyte transplantation. However, prior to grafting optimal recipient-site preparation is needed for graft survival and successful repigmentation outcomes. Similarly, post-operative care of the recipient site is vital to yielding a viable graft irrespective of the transplantation technique employed. This article reviews the multiple methods employed to prepare the recipient site in vitiligo surgeries and the post-surgical conditions which optimize graft viability. A pubmed search was conducted utilizing the key words listed below.

6.
Saudi J Kidney Dis Transpl ; 20(3): 488-92, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19414962

RESUMEN

Hepatitis C Virus (HCV) infection is a serious public health problem throughout the world. Patients with chronic renal failure are exposed to this infection. This could be due to a failure to identify carriers of this disease or because of lack of implementing truly effective safety measures in the dialysis units. This study was carried out in order to determine the prevalence of HCV infection and possible risk factors for acquiring it in patients on maintenance hemodialysis (HD). A total of 120 patients, 63 males (52%) and 57 females (42%), who were on regular HD in three military hospitals in the south of Jordan were studied during the period between January 2007 and April 2008. A total of 34 patients (28%) were HCV positive of whom, 20 were males (58%). The mean age of the study participants was 52.9 years. The means of age of HCV positive and negative patients were 51.5 and 54.4 years, respectively. Statistical analysis showed that four risk factors including history of blood transfusion, history of kidney transplantation, history of other surgeries and duration on HD, had an important role in acquiring HCV infection. Although the prevalence of HCV infection in our study patients is lower than in many other countries in the region, we believe that the prevalence is still high and reflects a serious challenge, which needs further research to identify the causes and to establish a well organized prophylactic program.


Asunto(s)
Hepatitis C/epidemiología , Enfermedades Renales/epidemiología , Enfermedades Renales/terapia , Diálisis Renal/estadística & datos numéricos , Femenino , Hepatitis C/etiología , Hepatitis C/prevención & control , Humanos , Jordania/epidemiología , Trasplante de Riñón/efectos adversos , Masculino , Persona de Mediana Edad , Prevalencia , Diálisis Renal/efectos adversos , Factores de Riesgo , Factores de Tiempo , Reacción a la Transfusión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA